Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 15;407(2):171-7.
doi: 10.1042/BJ20070552.

Activation-coupled membrane-type 1 matrix metalloproteinase membrane trafficking

Affiliations

Activation-coupled membrane-type 1 matrix metalloproteinase membrane trafficking

Yi I Wu et al. Biochem J. .

Abstract

The transmembrane collagenase MT1-MMP (membrane-type 1 matrix metalloproteinase), also known as MMP-14, has a critical function both in normal development and in cancer progression, and is subject to extensive controls at the post-translational level which affect proteinase activity. As zymogen activation is crucial for MT1-MMP activity, an alpha1-PI (alpha1-proteinase inhibitor)-based inhibitor was designed by incorporating the MT1-MMP propeptide cleavage sequence into the alpha1-PI reactive-site loop (designated alpha1-PI(MT1)) and this was compared with wild-type alpha1-PI (alpha1-PI(WT)) and the furin inhibitory mutant alpha1-PI(PDX). Alpha1-PI(MT1) formed an SDS-stable complex with furin and inhibited proMT1-MMP activation. A consequence of the loss of MT1-MMP activity was the activation of proMMP-2 and the inhibition of MT1-MMP-mediated collagen invasion. alpha1-PI(MT1) expression also resulted in the intracellular accumulation of a glycosylated species of proMT1-MMP that was retained in the perinuclear region, leading to significantly decreased cell-surface accumulation of proMT1-MMP. These observations suggest that both the subcellular localization and the activity of MT1-MMP are regulated in a coordinated fashion, such that proMT1-MMP is retained intracellularly until activation of its zymogen, then proMT1-MMP traffics to the cell surface in order to cleave extracellular substrates.

PubMed Disclaimer

Figures

Figure 1
Figure 1. A novel α1-PI variant based on the amino acid sequence flanking the proMT1-MMP activation site forms a SDS-stable complex with furin
(A) The amino acid sequence flanking the proMT1-MMP-activation site contains the optimal cleavage motif for furin and PC proteinases. A novel α1-PI variant, designated α1-PIMT1, was designed based on the sequence (P4–P2′) flanking the proMT1-MMP activation site. The altered sequence in the reactive-site loop (RSL) of α1-PIMT1 (P4–P2′) was aligned with the corresponding sequence of α1-PIWT and those of two other known α1-PI variants, α1-PIPitt and α1-PIPDX. (B) COS-7 cells were transiently transfected with a DNA plasmid encoding FLAG-tagged furin (Fur/f) in combination with plasmids encoding α1-PIWT (WT) or one of its variants α1-PIPitt (Pitt), α1-PIPDX (PDX) and α1-PIMT1 (MT1) respectively. Empty vectors (−) were used as controls in transfection. The cell lysates were prepared 24 h after transfection as described in the Experimental section and were fractionated by SDS/PAGE (5–20% gels) in duplicate, followed by Western blot analysis using an anti-α1-PI antibody (left-hand side) and anti-FLAG antibody (right-hand side). The immunopreciptates corresponding to α1-PI and furin alone and the α1-PI–furin (α1-PI–Fur) complex are indicated with arrows on the right-hand side.
Figure 2
Figure 2. α1-PIMT1 inhibits proMT1-MMP activation and prevents MT1-MMP-catalysed proMMP-2 activation
COS-7 cells were transiently transfected in duplicate with a DNA plasmid encoding FLAG-tagged MT1-MMP in combination with plasmids encoding α1-PIWT (WT) or different α1-PI variants α1-PIPitt (Pitt), α1-PIPDX (PDX) and α1-PIMT1 (MT1) respectively. The control cells (lane 1) were transfected with empty vectors (−). One set of transfected cells was incubated with 1 nM purified proMMP-2 in serum-free medium for 6 h, 18 h after transfection. The conditioned medium was analysed by gelatin zymography (top panel) as described in the Experimental section. The gelatinase activities corresponding to active MMP-2 and proMMP-2 are indicated with black and white arrowheads (top panel) respectively. The second set of transfected cells were analysed by SDS/PAGE, followed by Western blot analysis using an anti-FLAG antibody to detect MT1-MMP (middle panel) and an anti-(α1-PI) antibody (bottom panel) respectively. The immunoprecipitates corresponding to active MT1-MMP and proMT1-MMP are indicated with black and white arrowheads respectively.
Figure 3
Figure 3. α1-PIMT1 inhibits MT1-MMP-mediated collagen invasion
COS-7 cells were transiently transfected with (A) a vector or plasmid encoding MT1-MMP, or (B) with a plasmid encoding MT1-MMP in combination with a second plasmid encoding α1-PIWT or α1-PIPitt (Pitt), α1-PIPDX (PDX) and α1-PIMT1 (MT1) as indicated (right-hand side). After 24 h, the cells were analysed for three-dimensional collagen gel invasion as described in the Experimental section. Gel invasion is expressed as percentage invasion relative to cells transfected with vector (A) or cells transfected with both MT1-MMP and α1-PIWT (B).
Figure 4
Figure 4. α1-PIMT1 inhibition of proMT1-MMP activation results in the accumulation of glycosylated proMT1-MMP
(A) COS-7 cells were transiently transfected with a DNA plasmid encoding FLAG-tagged MT1-MMP or proMT1-MMP containing the activation site mutated to alanine residues (RRKR/A4), in combination with α1-PIWT or α1-PIMT1 respectively. Empty vector was used as a control. After 24 h, the cells were lysed, resolved by SDS/PAGE (10% gels) and analysed by Western blotting using an anti-FLAG antibody. The immunoprecipitates corresponding to activated MT1-MMP and proMT1-MMP are indicated with black and white arrowheads respectively. (B) COS-7 cells were transiently transfected with a DNA plasmid encoding FLAG-tagged MT1-MMP and also transfected with either α1-PIWT or α1-PIMT1, or were incubated with 10 μg/ml BFA (with DMSO used as vehicle control) respectively. The FLAG-tagged proteins were purified using anti-FLAG M2–agarose, followed by in vitro enzymatic de-glycosylation with sialydase A. The reaction mixtures were fractionated by SDS/PAGE (10% gels), followed by Western blot analysis using a polyclonal anti-[MT1-MMP (hinge region)] antibody. The immunoprecipitates corresponding to activated MT1-MMP and proMT1-MMP are indicated with black and white arrowheads respectively.
Figure 5
Figure 5. α1-PIMT1 induces perinuclear accumulation of endogenous MT1-MMP in MDA-MB-231 cells
(A) Cells were transfected with α1-PIWT and after 24 h, the cells were fixed with 3.7% (v/v) formalin and permeablized using 0.1% (v/v) Triton X-100. and immunostained using a rabbit anti-[MT1-MMP (hinge region)] antibody and a monoclonal mouse anti-EEA1 (early endosome antigen 1) antibody (B) Cells were stably transfected with α1-PIWT or α1-PIMT1 and, after 24 h, the cells were fixed with 3.7% (v/v) formalin and permeablized using 0.1% (v/v) Triton X-100. The cells were immunostained using a rabbit anti-[MT1-MMP (hinge region)] antibody and a monoclonal mouse anti-p58 (Golgi marker) monoclonal antibody. In both (A) and (B), the primary immunostaining was followed by Alexa Fluor® 488 -conjugated goat anti-(rabbit IgG) and Alexa Fluor® 546-conjugated goat anti-(mouse IgG) secondary antibodies. The images were acquired using a Zeiss LSM510 laser-scanning confocal microscope. Overlay images (MERGE) were generated using Adobe Photoshop software. Scale bar, 20 μm.
Figure 6
Figure 6. α1-PIMT1 inhibits cell-surface presentation of MT1-MMP
(A) MDA-MB-231 cells were stably transfected with either α1-PIWT or α1-PIMT1. The cell-surface proteins were biotinylated and purified as described in the Experimental section. The purified cell-surface proteins were fractionated in duplicate by SDS/PAGE (5–20% gels) under reducing conditions, followed by Western blot analysis using an anti-[MT1-MMP (hinge region)] antibody (top) and a mixture of anti-(α3 integrin heavy chain) and anti-(α3 integrin light chain) antibodies (middle) respectively. The cell lysate inputs before purification were analysed by Western blotting using an anti-α1-PI antibody (bottom). The immunoprecipitates corresponding to activated MT1-MMP and proMT1-MMP are indicated with black and white arrowheads respectively. (B) MDA-MB-231 cells stably expressing α1-PIWT or α1-PIMT1 were labelled on ice with an anti-[MT1-MMP (hinge region)] antibody and an anti-(α3 integrin) antibody (ASC-6), followed by staining with Alexa Fluor® 488- and 546-conjugated secondary antibodies respectively. The labelled cells were analysed by FACS for fluorescence intensities on both wavelengths. The means of fluorescence intensities for MT1-MMP and α3 integrin in the α1-PIMT1 cells are are compared with α1-PIWT cells (100%).

References

    1. Sternlicht M. D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001;17:463–516. - PMC - PubMed
    1. Mayer G., Boileau G., Bendayan M. Furin interacts with proMT1-MMP and integrin αV at specialized domains of renal cell plasma membrane. J. Cell Sci. 2003;116:1763–1773. - PubMed
    1. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S. A., Mankani M., Robey P. G., Poole A. R., Pidoux I., et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 1999;99:81–92. - PubMed
    1. Hotary K., Allen E., Punturieri A., Yana I., Weiss S. J. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 2000;149:1309–1323. - PMC - PubMed
    1. Hotary K. B., Allen E. D., Brooks P. C., Datta N. S., Long M. W., Weiss S. J. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell. 2003;114:33–45. - PubMed

Publication types

LinkOut - more resources